BlackRock Health Sciences Trust is set to trade ex-dividend for its next monthly payout of 0.262 per share on 08/14/26, with the dividend scheduled to be paid on 08/31/26. The stock’s recent “dividend run” pattern—where shares have historically firmed ahead of ex-dividend dates—will be closely watched by income-focused investors as the latest record date approaches.
Key takeaways
- Price move: In the last four ex-dividend cycles, a strategy focused on buying roughly two weeks before the ex-date generated capital gains in 3 out of 4 instances.
- Catalyst: BlackRock Health Sciences Trust’s next scheduled ex-dividend date is 08/14/26 for a 0.262 per share dividend.
- Implication: The data suggests there may be measurable upward drift ahead of ex-dates, but the pattern is not consistent every cycle.
- What to watch: Investors will likely track whether the shares follow the same pre-ex-date behavior leading into mid-August.
What “dividend run” means for this trust
On an ex-dividend date, new buyers are no longer entitled to the declared dividend for that period, meaning the stock price is often expected—all else equal—to adjust downward by approximately the dividend amount. The underlying logic behind a potential “dividend run” is that, if the price tends to drop on ex-date, investors may bid the shares up sometime beforehand to position for the upcoming cash payment.
Timeframes vary among dividend investors: some hold through ex-date, while others attempt to capture capital gains by entering earlier and exiting just before or around the ex-dividend window. One approach cited in the report centers on buying about two weeks (around 10 trading days) before the intended sale date.
Recent ex-dividend cycles and the two-week run-up
The article points to the trust’s behavior across its last four dividends using closing prices measured roughly two weeks prior to ex-date and again on the prior trading day. For the 0.262 per share dividend, the following runs were reported:
- 07/15/26 ex-dividend: Price closed at 42.91 about two weeks prior and 42.51 one day prior to ex-date, implying a -0.40 run.
- 06/15/26 ex-dividend: Price closed at 40.23 two weeks prior and 40.94 one day prior, implying a +0.71 run.
- 05/15/26 ex-dividend: Price closed at 39.32 two weeks prior and 39.63 one day prior, implying a +0.31 run.
- 04/15/26 ex-dividend: Price closed at 37.85 two weeks prior and 40.05 one day prior, implying a +2.20 run.
Aggregating those four cycles, the report states a “Divvy Run” total of +2.82 in capital gains, alongside total dividends across the same periods of 1.048. It also notes that while the distribution of outcomes is favorable more often than not, the pattern includes at least one down cycle.
Upcoming calendar and what investors are watching next
According to the schedule cited in the article, BlackRock Health Sciences Trust will go ex-dividend on 08/14/26 for the latest 0.262 per share payment, with the cash dividend expected on 08/31/26. With the next ex-date approaching in roughly two weeks from the time of the alert, the key practical question for income traders is whether the shares replicate the kind of pre-ex-date strength seen in three of the past four cycles.
Investors will also likely focus on whether market-wide factors—such as interest-rate expectations and broader sentiment toward closed-end funds and income-oriented equities—override the dividend-driven setup as the ex-date nears. The next datapoint to watch is the stock’s behavior in the final days leading into 08/14/26, as well as any management communications or broader market moves that could affect pricing independently of the dividend calendar.
